Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ECC 2013: Late Breaking Clinical Trials: ASPECCT

Written by | 15 Nov 2013

by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.

ECC 2013: Late Breaking Clinical Trials: EXPERT-C Trial results

Written by | 15 Nov 2013

Report by Esther Drain – Cetuximab resulted in a significant improvement in survival in TP53 WT, high-risk Rectal Cancer.

Video Interview: Professor Lenz and Professor Heinemann explain how they see biomarker testing in mCRC developing in practice following discussions at the ECC

Written by | 13 Nov 2013

Taken from the European Cancer Congress ( ECCO /  ESMO / ESTRO ) from the 27th September – 1st October 2013 in Amsterdam.

ESOT 2013 Report – Academic, industrial and regulatory barriers to progress in transplant immunosuppression

Written by | 21 Oct 2013

Randall Morris, San Francisco, USA – Failure to make therapeutic progress is a real challenge in the transplantation field. On the face of it, the goals set up… read more.

ESOT 2013 Report – Today’s patients, tomorrow’s outcomes: how can we manage risk factors to improve graft survival in renal transplantation?

Written by | 17 Oct 2013

by Maria Dalby – Kidney transplants could in principle last forever – the common assumption that kidney transplants inevitably deteriorate and fail is not supported by the latest… read more.

Highlights from the 2013 European Society for Organ Transplantation (ESOT) meeting in Vienna

Written by | 15 Oct 2013

by Mr Nizam Mamode (pictured) – This year’s European Society for Organ Transplantation meeting, held in Vienna, saw a concerted attempt at providing a high quality congress for… read more.

Press Release – Future doctors unprepared to manage pain – one of the most common problems they will encounter in clinical practice, expert group warns

Written by | 11 Oct 2013

First ever Europe-wide study reveals that even when undergraduate medical students take a compulsory course on pain, they still only receive on average 12 hours’ training

Press Release – Halaven® data presented at ECCO 2013

Written by | 11 Oct 2013

17th ECCO – 38th ESMO – 32nd ESTRO – European Cancer Congress, Amsterdam RAI, 27 Sept – 1 Oct 2013. Eribulin represents a novel class of antineoplastic agents… read more.

ERS Report 2013 -1 in 10 of all deaths in Europe and cost EU countries at least 400 billion Euros annually; deaths due to lung cancer and COPD projected to increase

Written by | 11 Oct 2013

A major new publication from the European Respiratory Society (ERS) ahead of its annual congress, shows that lung conditions are responsible for 1 in 10 of all deaths… read more.

ERS Report 2013 – Sleep apnoea linked with increased risk of cancer death

Written by | 9 Oct 2013

Sleep apnoea severity has been associated with increased cancer mortality in a new study.

Integrative medicine interventions found to significantly reduce pain, improve quality of life

Written by | 30 Sep 2013

New study points to sustainable effects of patient-centered care.

Opioid use increases without improvements in treatment of pain

Written by | 25 Sep 2013

by Bruce Sylvester – Researchers report that, after a decade when prescription opioid use has grown dramatically, identification and treatment of pain has not improved, and, notably, the… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.